These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31432447)

  • 41. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
    Koo BK; Joo SK; Kim D; Bae JM; Park JH; Kim JH; Kim W
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1277-1285. PubMed ID: 29193269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; McNeil R; Turner MJ; Han B; Provenzale D; Choi SS; Moylan CA; Hunt CM
    Aliment Pharmacol Ther; 2018 Jan; 47(2):268-278. PubMed ID: 29115682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver Disease.
    Pisetta C; Chillè C; Pelizzari G; Pigozzi MG; Salvetti M; Paini A; Muiesan ML; De Ciuceis C; Ricci C; Rizzoni D
    High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):321-330. PubMed ID: 32436128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients.
    Turan MN; Gungor O; Asci G; Kircelli F; Acar T; Yaprak M; Ceylan N; Demirci MS; Bayraktaroglu S; Toz H; Ozkahya M; Ok E
    Atherosclerosis; 2013 Jan; 226(1):129-33. PubMed ID: 23159099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epicardial and paracardial adipose tissue volume and attenuation - Association with high-risk coronary plaque on computed tomographic angiography in the ROMICAT II trial.
    Lu MT; Park J; Ghemigian K; Mayrhofer T; Puchner SB; Liu T; Fleg JL; Udelson JE; Truong QA; Ferencik M; Hoffmann U
    Atherosclerosis; 2016 Aug; 251():47-54. PubMed ID: 27266821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
    Tana C; Tana M; Rossi S; Silingardi M; Schiavone C
    J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased epicardial adipose tissue is associated with coronary artery disease and major adverse cardiovascular events.
    Hajsadeghi F; Nabavi V; Bhandari A; Choi A; Vincent H; Flores F; Budoff M; Ahmadi N
    Atherosclerosis; 2014 Dec; 237(2):486-9. PubMed ID: 25463078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness.
    Li N; Zhang GW; Zhang JR; Jin D; Li Y; Liu T; Wang RT
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):218-23. PubMed ID: 25456154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between epicardial adipose tissue and blood pressure: A systematic review and meta-analysis.
    Guan B; Liu L; Li X; Huang X; Yang W; Sun S; Ma Y; Yu Y; Luo J; Cao J
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2547-2556. PubMed ID: 34172321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
    Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
    World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A concise review of non-alcoholic fatty liver disease.
    Than NN; Newsome PN
    Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis.
    Guo Z; Li M; Han B; Qi X
    Dig Liver Dis; 2018 Nov; 50(11):1153-1162. PubMed ID: 30224316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epicardial Adipose Tissue in Cardiovascular Disease.
    Berg G; Miksztowicz V; Morales C; Barchuk M
    Adv Exp Med Biol; 2019; 1127():131-143. PubMed ID: 31140176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.